Genentech News
Most Popular Genentech Story
Genentech breathes new life into failed breast cancer drug
Genentech ($DNA) has found a new use for a failed drug. At the annual CTRC-AACR San Antonio Breast Cancer Symposium, the drugmaker revealed that pertuzumab and Herceptin in addition to chemotherapy... Read more...
Latest Headlines
- December 15, 2010
- December 10, 2010
- November 5, 2010
- October 11, 2010
- September 9, 2010
- August 27, 2010
- August 3, 2010
- July 26, 2010
- July 12, 2010
- July 2, 2010
- May 10, 2010
- March 25, 2010
- February 19, 2010
- February 3, 2010
- February 1, 2010
- December 21, 2009
Paid Research Reports
- Russia Pharmaceutical Market Overview - Pharma companies target Russia despite the challenges it presents
- Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative) - Triple-negative breast cancer offers a significant opportunity
- Infectious Diseases Vaccine Market Overview
- Commercial Insight: Top 20 Cancer Therapy Brands
- Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issue
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
